Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ase Industrial Holding Ltd ADR
(NY:
ASX
)
9.880
+0.320 (+3.35%)
Official Closing Price
Updated: 7:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Ase Industrial Holding Ltd ADR
< Previous
1
2
3
4
5
Next >
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
October 31, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
ASE “Guardians of the Sea” Wins Gold at the PwC Sustainability Impact Awards
October 25, 2024
From
Advanced Semiconductor Engineering, Inc.
Via
Business Wire
Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy
October 17, 2024
Temporary marketing authorization is based on statistically significant and clinically meaningful results from the Phase 3 PROTECT Trial
From
Travere Therapeutics, Inc.
Via
GlobeNewswire
Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer
October 14, 2024
From
Cogstate Ltd.
Via
GlobeNewswire
Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
October 14, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
October 11, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
ATHA Energy Announces Option Agreements With Terra Uranium for Spire, Horizon, and Pasfield Projects
October 11, 2024
From
ATHA Energy Corp.
Via
GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for October 10th
October 07, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
October 02, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Novo Resources to Present at the Battery and Precious Metals Virtual Investor Conference October
September 30, 2024
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
September 30, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
September 23, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Life360 Set to Join Russell 2000® and 3000® Indexes
September 17, 2024
From
Life360, Inc.
Via
GlobeNewswire
Clean Energy Metals Virtual Investor Conference Agenda Announced for August 29th
August 27, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
July 31, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Global Uranium and Enrichment to Present at the OTCQB Venture Virtual Investor Conference August 1st
July 29, 2024
Global Uranium invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Alterity Therapeutics to Present at MST Financial Webinar
July 24, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Discover the Hidden Gem in Chip Manufacturing Stocks
July 24, 2024
ASE Technology Holding Co. Ltd. (NYSE: ASX) is a Taiwan-based semiconductor manufacturing company you’ve probably never heard of.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
July 17, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
ISE Labs Expands Capabilities, Doubles Lab Space with Opening of Second Silicon Valley Location
July 11, 2024
From
Advanced Semiconductor Engineering, Inc.
Via
Business Wire
OTC Markets Group Welcomes Sovereign Metals Limited to OTCQX
July 05, 2024
From
OTC Markets
Via
GlobeNewswire
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
July 04, 2024
From
CSL Behring
Via
GlobeNewswire
ASE Holdings Hosts Annual Supplier Day to Recognize Outstanding Suppliers of 2023
June 13, 2024
From
ASE Technology Holding Co., Ltd.
Via
Business Wire
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
June 12, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Small-Cap Growth Virtual Investor Conference Agenda Announced for June 13th
June 11, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
May 29, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
ASE Introduces powerSiP™ for Transformative Power Delivery That Increases Power Efficiencies by 50% in AI and Data Center Applications
May 29, 2024
From
Advanced Semiconductor Engineering, Inc.
Via
Business Wire
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access
May 16, 2024
The alliance with Health Gorilla will provide MatrixCare customers with more than 220 million patient records to streamline workflows and improve patient outcomes.
From
MatrixCare
Via
GlobeNewswire
OTC Markets Group Welcomes Neometals Ltd. to OTCQX
May 15, 2024
From
OTC Markets
Via
GlobeNewswire
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
May 08, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.